<DOC>
	<DOCNO>NCT02367196</DOCNO>
	<brief_summary>CC-90002-ST -001 open-label , Phase 1 , dose escalation expansion clinical study subject advance , refractory solid hematologic cancer .</brief_summary>
	<brief_title>A Phase 1 , Dose Finding Study CC-90002 Subjects With Advanced Solid Hematologic Cancers</brief_title>
	<detailed_description>CC-90002-ST-001 open-label , Phase 1 , dose escalation expansion , first human ( FIH ) clinical study CC-90002 , administer intravenous ( IV ) infusion , subject advance , refractory solid hematologic cancer . The study conduct two part . Following completion dose escalation ( Part A ) , select hematologic solid tumor cohort may enrol expansion phase ( Part B ) .</detailed_description>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>1 . Men woman , 18 year old , advance , relapse refractory solid tumor , Multiple Myeloma ( MM ) nonHodgkin 's lymphoma ( NHL ) . 2 . At least one site measurable disease subject solid tumor NHL . 3 . Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) 0 1 . 4 . Subjects must adequate hematopoietic , liver , renal coagulation function assess specific laboratory criterion . 5 . Females male must agree contraceptive method avoid conceive throughout study , 8 week follow last dose CC90002 . 1 . High grade lymphoma ( Burkitts lymphoblastic ) , plasma cell leukemia.2 . High grade , rapidly proliferative solid tumor ( eg , small cell lung cancer , germ cell tumor , neuroblastoma ) extensive tumor burden . 3 . Symptomatic central nervous system involvement . 4 . Impaired cardiac function clinically significant cardiac disease . 5 . Prior Red blood cell ( RBC ) transfusion &lt; 3 month prior start CC90002 . 6 . Prior autologous stem cell transplant ≤ 3 month prior start CC90002 . 7 . Prior allogeneic stem cell transplant either standard reduce intensity conditioning ≤ 6 month prior start CC90002 . 8 . Prior systemic cancerdirected treatment investigational modality ≤ 5 half live 4 week prior start CC90002 , whichever short . 9 . Major surgery ≤ 2 week prior start CC90002 . 10 . Pregnant nursing female . 11 . Known HIV infection . 12 . Known chronic hepatitis B C ( HBV/HCV ) infection . 13 . Ongoing treatment chronic , therapeutic dosing anticoagulant . 14 . History autoimmune hemolytic anemia autoimmune thrombocytopenia . 15 . History concurrent second cancer require active , ongoing systemic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CC-90002</keyword>
	<keyword>Monoclonal</keyword>
	<keyword>Antibody</keyword>
	<keyword>CD47</keyword>
	<keyword>Advanced</keyword>
	<keyword>Solid Cancers</keyword>
	<keyword>Hematologic Cancers</keyword>
</DOC>